This compound is primarily utilized in pharmaceutical research and development due to its unique structural properties. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting drugs, making it valuable in the design of central nervous system (CNS) therapeutics. Additionally, it is explored in the creation of novel antidepressants and anxiolytics, where its cyclopropane ring contributes to the compound's rigidity and receptor binding efficiency. Researchers also investigate its potential in developing anti-inflammatory and analgesic agents, leveraging its ability to modulate specific enzyme pathways.